Conflu3nce

A health technology company targeting early disease detection.

Health Tech & Life Sciences
Active
Pre-Seed Jerusalem, Israel Founded 2016
Last updated 2026-07-20
Total raised
$30K
Last: Grant 2020-03
Stage
Pre-Seed
Founded
2016
Headcount
1
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

Conflu3nce is a health technology company focused on early disease detection. The company leverages a novel multiplexed visual stimulus, integrated into its PICSSi COGnomics platform, to individualize cognitive health markers for personalized cognitive health profiling. Conflu3nce develops patented image-based technologies to advance early detection and predictive insight across industries, from spotting critical anomalies in manufacturing to detecting emerging safety risks in autonomous systems, and identifying subtle signals in healthcare and scientific research. The cornerstone of the company's product development initiative is the patented Stitch n' Peel (SnP) method, which logically juxtaposes non-contiguous image sections to identify long-term dependencies within an image.

Funding history · 2 rounds · $30K total

2020-02
Grant $30K
2018-02
Pre-Seed Extension Undisclosed
★ PSC, LLC

Headcount over time

From 6 (2023-03) to 1 (2024-08) · -5 (-83%) · 2 points · source: Finder history + radar grounding
60 2023-03 2024-08

Q&A

What is Conflu3nce's primary focus?
Conflu3nce focuses on the early detection of cognitive health changes using patented methods and is developing PICSSi, a system for cognitive-motor issues.
What technology does Conflu3nce utilize for its solutions?
Conflu3nce's PICSSi and Stitch and Peel (SnP) technology is based on processes and methods that use content-rich, dynamic, 3D-like figure-ground image sets with manipulable and predictable image properties.
When was Conflu3nce founded?
Conflu3nce was founded in April 2016.
How many employees does Conflu3nce currently have?
Conflu3nce has 1-10 employees.
What is Conflu3nce's total funding to date?
Conflu3nce has raised a total of $330,000 USD.
When was Conflu3nce's last funding round and who participated?
Conflu3nce's last funding round was a Grant in March 2020, with participation from Jerusalem Development Authority.
Who is the Founder and CEO of Conflu3nce?
Tami Ellison is the Founder & CEO of Conflu3nce.
Does Conflu3nce hold any patents?
Yes, Conflu3nce holds 1 patent.

Team · 1

Tami Ellison
Founder · CEO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Therapeutics
Technologies
Artificial IntelligenceComputer VisionPlatforms & InterfacesSoftwareSimulation & Imaging
Target customers
Healthcare & Life SciencesHealthcarePatients
Business model
B2BB2CB2B2C

Highlights

1 PatentsVerified

Tags

neurology3d-technologyneuro-stimulationalzheimers-diseaseinsurance-companiesnon-invasiveparkinsonmedical-devicesearly-detectioncomputer-visionartificial-intelligencehealthcare-providersmobile-applicationsseniorshospitalspharma-companiesdiagnosticstrainingdigital-healthcareadhddegenerative-diseasescognitive-trainingtreatmentsimage-processingdigital-therapeuticsrehabilitation
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteconflu3nce.com/cgi-sys/suspendedpage.cgi
LinkedInlinkedin.com/company/67281552
YouTubeyoutube.com/channel/UC-M9Bl7zkbKF00AYxd-Sm_g

Identifiers & details

Founded2016-4
Employees (exact)1
OfficesDenver

Radar intelligence

Patents

EPO8

Web history (Wayback)

Domainconflu3nce.com

Certificate / subdomain footprint

Subdomains11

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)515436921
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2016-04-07
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2025
Active charges / liens0
Registry events0
Registered addressיד חרוצים 18 ירושלים